Transcripts

Collegium Pharmaceutical (COLL) earnings call transcripts

Earnings call transcripts for Collegium Pharmaceutical, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed ADHD expansion as the primary growth engine while positioning pain as a durable cash-generation base for disciplined capital deployment.

    Aug 06, 2026Confident0.72